Clinical trials are structured studies that examine the performance of investigational drugs in human patients.

This section of the Calando Pharmaceuticals website provides an update on the status of our clinical trials.

IT-101 Clinical Trials

Phase I Clinical Trial - Currently Recruiting

This is an open-label, dose-escalation study of IT-101 administered in patients with solid tumor malignancies. Patients who satisfy the inclusion/exclusion criteria will receive injections of IT-101 every other week. Patients will be monitored for a response using RECIST criteria every 2 months.

For additional information please visit Clinicaltrials.gov